The aim of this study was to evaluate the value of microvascular obstruction (MO) and infarct size as a percentage of left ventricular mass (IS%LV), as measured by contrast-enhanced cardiac magnetic resonance, in predicting major cardiovascular adverse events (MACE) at 2 years in patients with ST-segment elevation myocardial infarction reperfused by primary percutaneous coronary intervention. Individual data from 1,025 patients were entered into the pooled analysis. MO was associated with the occurrence of MACE, defined as a composite of cardiac death, congestive heart failure, and myocardial re-infarction (adjusted hazard ratio: 3.74; 95% confidence interval: 2.21 to 6.34). IS% LV $25% was not associated with MACE (adjusted hazard ratio: 0.90; 95% confidence interval: 0.59 to 1.37).
or inadequate myocardial tissue reperfusion despite successful reopening of the infarct-related artery (3) .
No-reflow is thought to be a consequence of microvascular obstruction (MO), caused by numerous components, including distal atherothrombotic embolization, ischemic injury, reperfusion injury, and susceptibility of the coronary microcirculation to injury (2) . No-reflow can be assessed with cine coronary angiography, ST-segment resolution measured on electrocardiography, and noninvasive imaging techniques such as myocardial contrast echocardiography and contrast-enhanced cardiac magnetic resonance (CE-CMR).
In patients with STEMI, the presence and thickening during follow-up study (5) . Moreover, MO is an important predictor of global functional recovery after STEMI (6) . Several studies suggest that MO is associated with worse prognosis (7) (8) (9) (10) (11) (12) (13) .
However, previous studies in this regard have been hampered by a limited number of patients, evaluated a combined clinical endpoint, and were single-center studies (7) (8) (9) (10) (11) (12) (13) . Furthermore, although intuitively IS measured within 2 weeks after STEMI is an important independent determinant of outcome, there is conflicting evidence to support its independent predictive value for major adverse cardiac events (MACE) (9, 12, 14) .
We performed a meta-analysis of individual patient data to evaluate the hypotheses that MO and Queries were sent to the primary investigators in cases in which further data and clarification were needed.
DEFINITIONS/CE-CMR. STEMI was defined on the basis of the definitions used by the authors of the primary publications (8) (9) (10) (11) (12) (13) 18, 19) . All clinical and angiographic variables were study based. Angiographic left main coronary artery lesions were categorized as left anterior descending artery lesions.
Imaging was performed in different centers on 1.5-T scanners from different vendors (Online Table 1 ).
The scanning protocols, CE-CMR parameters, and data analysis have been described in the included studies (8) (9) (10) (11) (12) (13) 18, 19) . All investigators but one used a steady-state, free-precession sequence for cine CMR (Online Table 1 ). LV end-diastolic volume, LV end- ENDPOINTS. The primary endpoint was the prevalence of major adverse cardiovascular events (MACE), defined as a composite of cardiac death, myocardial re-infarction, and new congestive heart failure, at 2 years. The secondary endpoint was cardiac mortality. Congestive heart failure was defined as any symptom of cardiac decompensation requiring hospitalization. The individual study investigators provided previously defined and used events (Online Table 1 ). If a patient experienced more than one event, the first event was chosen for the com- van Kranenburg et al.
Prognostic Value of Microvascular Obstruction For both LVEF and IS%LV, nonlinear relationships were observed (Figures 3 and 4) . Therefore, these 2 variables were categorized using tertiles, which provides a large number of events per category while respecting nonlinearity. For LVEF, the first tertile (cutoff: 42.7%, simplified to #40%, used in the CADILLAC risk score [15] ) was compared to the reference group (LVEF >40%). For IS%LV, the last tertile (cutoff: 24.7%, simplified to $25%) was compared to the reference group (IS%LV <25%).
The Kaplan-Meier estimate of freedom from MACE at 2 years was 74.3% in patients with IS%LV $25% versus 87.4% in patients with IS%LV <25% (p < 0.001). Kaplan-Meier curves for MACE by MO and IS%LV in the entire cohort, and grouped by MO and Univariate Cox regression is summarized in Values are mean AE SD, n (%), n/N (%), or median (IQR). Data missing in the following number of cases: *124 (12.1%), †88 (8.6%), ‡77 (7.5%), §78 (7.6%), k278 (27.1%), and ¶446 (43.5%) (reperfusion within 12 h). #Data missing in >7.5% of the cohort. Univariate Cox regression is summarized in 
DISCUSSION
The main findings of this study were that: 1) MO was present in >50% of patients with STEMI reperfused by pPCI (even in patients with TIMI flow grade post pPCI of 3, MO was present in >50% of patients); 2) MO, IS%LV, and LVEF were predictors for MACE, with value added to clinical risk factors; 3) MO was aHR ¼ adjusted hazard ratios; other abbreviations as in Tables 1 and 2 . Model a: age þ multivessel disease þ TIMI flow grade after PCI 0.59
Model c: age þ multivessel disease þ TIMI flow grade after PCI þ LVEF #40% 0.66
Abbreviations as in Tables 1 and 2 .
van Kranenburg et al. Tables 1 and 2 . Abbreviations as in Tables 1, 2, and 3 .
van Kranenburg et al. In this analysis, we evaluated the prognostic value of MO only, without investigation of the extent of MO. A previous study (12) showed that the extent of MO provided incremental prognostic information.
Unfortunately, this variable was available in only one study and therefore could not be included in the pooled analysis.
In cases of missing data, variables that may have influenced the primary endpoint (e.g., extent of MO, myocardial salvage [27] , and the presence of a hypointense infarct core [28] ) were not taken into account.
Due to a low cardiac death rate, we were not able to add more variables in the multivariate Cox regression analysis. 
CONCLUSIONS

